Fig. 1From: Risk of heart failure hospitalization among users of dipeptidyl peptidase-4 inhibitors compared to glucagon-like peptide-1 receptor agonistsRisk of hospitalization due to heart failure with DPP-4 inhibitors versus GLP-1 agonists in propensity score matched analysesBack to article page